Glucoză Infomed Fluids (Glucose Monohydrate)

Glucoză Infomed Fluids is employed in several clinical situations where rapid glucose delivery and fluid replacement are required.

• Management of hypoglycemia when oral glucose is not feasible.
• Component of parenteral nutrition regimens for patients unable to receive enteral feeding.
• Support of fluid and electrolyte balance during peri‑operative care.
• Provision of an energy substrate during prolonged fasting or critical illness.
• Adjunctive therapy for patients receiving intravenous medications that may lower blood glucose.
• Use as a diluent for certain intravenous drug preparations requiring a carbohydrate carrier.

When administered intravenously, Glucoză Infomed Fluids may be associated with a range of observed effects, most of which are related to its glucose content and osmolarity.

Common

• Transient hyperglycemia, especially in patients with impaired insulin response.
• Mild local irritation at the infusion site.
• Electrolyte shifts such as mild hyponatremia.
• Increased urine output due to osmotic diuresis.
• Nausea or vomiting when infused rapidly.
• Headache related to rapid changes in plasma glucose.

Serious

• Severe hyperglycemia leading to osmotic diuresis and dehydration.
• Hypotension or fluid overload in patients with compromised cardiac function.
• Allergic or anaphylactoid reaction to the solution constituents.

Clinical use of Glucoză Infomed Fluids requires careful assessment of patient condition and monitoring to minimize risks.

• Verify blood glucose level before and during infusion to avoid extreme hyperglycemia.
• Assess cardiac and renal function, as excess fluid may precipitate overload.
• Adjust infusion rate in patients with known electrolyte disturbances.
• Use caution in pregnant or lactating individuals; safety data are limited.
• Avoid administration to patients with known hypersensitivity to glucose solutions.
• Monitor serum electrolytes and osmolality regularly during prolonged therapy.
• Ensure aseptic technique to prevent catheter‑related infections.

Glucoză Infomed Fluids can influence the pharmacokinetics or pharmacodynamics of several concurrently administered agents.

Avoid

• Concurrent high‑dose insulin therapy without glucose monitoring, which may precipitate severe hypoglycemia.
• Co‑administration with other hypertonic carbohydrate solutions, increasing risk of fluid overload.
• Use with medications that contain potassium or other electrolytes in concentrations that could exacerbate electrolyte imbalance.

Use with caution

• Diuretics, which may amplify electrolyte shifts when combined with glucose infusion.
• Beta‑adrenergic agonists, as they can enhance glycogenolysis and raise glucose levels.
• Corticosteroids, which may increase blood glucose and require closer monitoring.